Edmonds, WA, United States of America

Steven C Quay

USPTO Granted Patents = 93 

 

 

Average Co-Inventor Count = 1.9

ph-index = 28

Forward Citations = 2,493(Granted Patents)

Forward Citations (Not Self Cited) = 2,397(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Menlo Park, CA (US) (1987 - 1989)
  • Palo Alto, CA (US) (1992)
  • Los Altos Hills, CA (US) (1989 - 1993)
  • Sunnyvale, CA (US) (1994)
  • Los Angeles, CA (US) (1995 - 1996)
  • Pacific Palisades, WA (US) (1999)
  • Wayne, PA (US) (2001)
  • Pacific Palisades, CA (US) (1995 - 2004)
  • Woodinville, WA (US) (2011 - 2015)
  • Edmonds, WA (US) (1998 - 2016)
  • Seattle, WA (US) (2011 - 2024)

Company Filing History:


Years Active: 1987-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Endoxifen
Intranasal Delivery
Amino Acid Lipids
Breast Cancer Detection
Mucosal Delivery
Oxytocin Analogues
Ultrasound Imaging
Therapeutics Delivery
Nucleic Acid Molecules
Fatty Acid Compositions
Peptide YY
Obesity Treatment
93 patents (USPTO):Explore Patents

Title: Steven C. Quay: Innovator in Pharmaceutical Applications

Introduction

Steven C. Quay is a prominent inventor based in Edmonds, WA, who has made significant contributions to the field of pharmaceuticals, holding an impressive total of 88 patents. His innovative work primarily focuses on methods related to hormone-dependent disorders, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest patents, Quay has developed methods for making and using endoxifen. This disclosure details industrially scalable methods for producing (Z)-endoxifen or its salts, as well as various crystalline forms of endoxifen. The patents also emphasize formulations aimed at treating hormone-dependent breast conditions and reproductive tract disorders, marking a significant milestone in pharmaceutical development.

Career Highlights

Quay's professional journey includes vital roles at Salutar, Inc. and Sonus Pharmaceuticals, Inc. His experience at these companies allowed him to refine his expertise in drug development, underpinning his patent work with solid practical knowledge and innovation.

Collaborations

Throughout his career, Quay has collaborated with notable professionals such as Scott M. Rocklage and Anthony P. Sileno. These partnerships have further enriched his research and invention capabilities, fostering an environment of shared expertise and progress in therapeutic advancements.

Conclusion

Steven C. Quay exemplifies the spirit of innovation in the pharmaceutical sector. His dedication to creating scalable methods for critical medical treatments reflects not only his expertise as an inventor but also his commitment to improving patient care. Quay's contributions continue to inspire advances in the treatment of hormone-dependent disorders and exemplify the vital role of patented inventions in achieving medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…